1,147
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

, , , , , , , , & show all
Pages 208-213 | Received 01 Oct 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ying-Zheng Zhao, Cui-Tao Lu, Xiao-Kun Li & Jun Cai. (2013) Ultrasound-mediated strategies in opening brain barriers for drug brain delivery. Expert Opinion on Drug Delivery 10:7, pages 987-1001.
Read now
Tindara Franchina, Barbara Adamo, Giuseppina R.R. Ricciardi, Nicola Caristi, Rita Maria Agostino, Claudia Proto & Vincenzo Adamo. (2012) Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement. Cancer Biology & Therapy 13:7, pages 472-476.
Read now
Iain RJ Macpherson & TR Jeffry Evans. (2009) New approaches in the management of advanced breast cancer – role of combination treatment with liposomal doxorubicin. Breast Cancer: Targets and Therapy 1, pages 1-18.
Read now
Alessandro M Minisini, Claudia Andreetta, Gianpiero Fasola & Fabio Puglisi. (2008) Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer. Expert Review of Anticancer Therapy 8:3, pages 331-342.
Read now

Articles from other publishers (5)

Patricia Martin-Romano, Iosune Baraibar, Jaime Espinós, Jairo Legaspi, Jose M. López-Picazo, Jose Manuel Aramendía, Oscar A. Fernández & Marta Santisteban. (2018) Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. The Breast Journal 24:4, pages 473-479.
Crossref
Ayman Shafei, Wesam El-Bakly, Ahmed Sobhy, Omar Wagdy, Ahmed Reda, Omar Aboelenin, Amr Marzouk, Khalil El Habak, Randa Mostafa, Mahmoud A. Ali & Mahmoud Ellithy. (2017) A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer. Biomedicine & Pharmacotherapy 95, pages 1209-1218.
Crossref
Cristina Grange, Simonetta Geninatti-Crich, Giovanna Esposito, Diego Alberti, Lorenzo Tei, Benedetta Bussolati, Silvio Aime & Giovanni Camussi. (2010) Combined Delivery and Magnetic Resonance Imaging of Neural Cell Adhesion Molecule–Targeted Doxorubicin-Containing Liposomes in Experimentally Induced Kaposi's Sarcoma. Cancer Research 70:6, pages 2180-2190.
Crossref
Natalia Vykhodtseva, Nathan McDannold & Kullervo Hynynen. (2008) Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics 48:4, pages 279-296.
Crossref
V Adamo, V Lorusso, R Rossello, B Adamo, G Ferraro, D Lorusso, G Condemi, D Priolo, L Di Lullo, A Paglia, S Pisconti, G Scambia & G Ferrandina. (2008) Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. British Journal of Cancer 98:12, pages 1916-1921.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.